🇺🇸 ORAVESCENT Fentanyl Citrate in United States

15 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Loss Of Consciousness — 3 reports (20%)
  2. Accidental Overdose — 2 reports (13.33%)
  3. Respiratory Distress — 2 reports (13.33%)
  4. Suicide Attempt — 2 reports (13.33%)
  5. Abdominal Pain — 1 report (6.67%)
  6. Amnesia — 1 report (6.67%)
  7. Anaemia — 1 report (6.67%)
  8. Anion Gap Decreased — 1 report (6.67%)
  9. Atrioventricular Block First Degree — 1 report (6.67%)
  10. Balance Disorder — 1 report (6.67%)

Source database →

Other Pain Management approved in United States

Frequently asked questions

Is ORAVESCENT Fentanyl Citrate approved in United States?

ORAVESCENT Fentanyl Citrate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for ORAVESCENT Fentanyl Citrate in United States?

Cephalon is the originator. The local marketing authorisation holder may differ — check the official source linked above.